More articles from Chromatin, Epigenetics, and RNA Regulation

Reversal of Triple-Negative Breast Cancer EMT by miR-200c Decreases Tryptophan Catabolism and a Program of Immunosuppression
Thomas J. Rogers, Jessica L. Christenson, Lisa I. Greene, Kathleen I. O'Neill, Michelle M. Williams, Michael A. Gordon, Travis Nemkov, Angelo D'Alessandro, Greg D. Degala, Jimin Shin, Aik-Choon Tan, Diana M. Cittelly, James R. Lambert, Jennifer K. Richer

Molecular Cancer Research Jan 2019, 17 (1) 30-41; DOI: 10.1158/1541-7786.MCR-18-0246
Nomogram Integrating Genomics with Clinicopathologic Features Improves Prognosis Prediction for Colorectal Cancer
Yongfu Xiong, Wenxian You, Min Hou, Linglong Peng, He Zhou, Zhongxue Fu

Molecular Cancer Research Sep 2018, 16 (9) 1373-1384; DOI: 10.1158/1541-7786.MCR-18-0063
SMARCB1 Deficiency Integrates Epigenetic Signals to Oncogenic Gene Expression Program Maintenance in Human Acute Myeloid Leukemia
Shankha Subhra Chatterjee, Mayukh Biswas, Liberalis Debraj Boila, Debasis Banerjee, Amitava Sengupta

Molecular Cancer Research May 2018, 16 (5) 791-804; DOI: 10.1158/1541-7786.MCR-17-0493
Divergent Activity of the Pseudogene PTENP1 in ER-Positive and Negative Breast Cancer
Synnøve Yndestad, Eilin Austreid, Kai Ove Skaftnesmo, Per Eystein Lønning, Hans Petter Eikesdal

Molecular Cancer Research Jan 2018, 16 (1) 78-89; DOI: 10.1158/1541-7786.MCR-17-0207
Functional Impact of Chromatin Remodeling Gene Mutations and Predictive Signature for Therapeutic Response in Bladder Cancer
Jason E. Duex, Kalin E. Swain, Garrett M. Dancik, Richard D. Paucek, Charles Owens, Mair E.A. Churchill, Dan Theodorescu

Molecular Cancer Research Jan 2018, 16 (1) 69-77; DOI: 10.1158/1541-7786.MCR-17-0260
FOXD3 Regulates CSC Marker, DCLK1-S, and Invasive Potential: Prognostic Implications in Colon Cancer
Shubhashish Sarkar, Malaney R. O'Connell, Yoshinaga Okugawa, Brian S. Lee, Yuji Toiyama, Masato Kusunoki, Robert D. Daboval, Ajay Goel, Pomila Singh

Molecular Cancer Research Dec 2017, 15 (12) 1678-1691; DOI: 10.1158/1541-7786.MCR-17-0287
Dual Src Kinase/Pretubulin Inhibitor KX-01, Sensitizes ERα-negative Breast Cancers to Tamoxifen through ERα Reexpression
Muralidharan Anbalagan, Mei Sheng, Brian Fleischer, Yifang Zhang, Yuanjun Gao, Van Hoang, Margarite Matossian, Hope E. Burks, Matthew E. Burow, Bridgette M. Collins-Burow, David Hangauer, Brian G. Rowan

Molecular Cancer Research Nov 2017, 15 (11) 1491-1502; DOI: 10.1158/1541-7786.MCR-16-0297-T
Interferon-Stimulated Genes Are Transcriptionally Repressed by PR in Breast Cancer
Katherine R. Walter, Merit L. Goodman, Hari Singhal, Jade A. Hall, Tianbao Li, Sean M. Holloran, Gloria M. Trinca, Katelin A. Gibson, Victor X. Jin, Geoffrey L. Greene, Christy R. Hagan

Molecular Cancer Research Oct 2017, 15 (10) 1331-1340; DOI: 10.1158/1541-7786.MCR-17-0180
FOXC1 Regulates FGFR1 Isoform Switching to Promote Invasion Following TGFβ-Induced EMT
Alex Hopkins, Mackenzie L. Coatham, Fred B. Berry

Molecular Cancer Research Oct 2017, 15 (10) 1341-1353; DOI: 10.1158/1541-7786.MCR-17-0185
Inhibition of the Cell Death Pathway in Nonalcoholic Steatohepatitis (NASH)-Related Hepatocarcinogenesis Is Associated with Histone H4 lysine 16 Deacetylation
Aline de Conti, Kostiantyn Dreval, Volodymyr Tryndyak, Orish E. Orisakwe, Sharon A. Ross, Frederick A. Beland, Igor P. Pogribny

Molecular Cancer Research Sep 2017, 15 (9) 1163-1172; DOI: 10.1158/1541-7786.MCR-17-0109

Main menu

User menu

Search

More articles from Chromatin, Epigenetics, and RNA Regulation

Pages

Articles

Information for

About MCR